Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapse-remitting Multiple Sclerosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)UnknownNCT02325440
What this trial is testing

Study to Assess Immune Function and MRI Disease Activity in RRMS Patients When Switching From Natalizumab to Gilenya

Who this might be right for
Relapsing Remitting Multiple Sclerosis
University Hospital Muenster 15
Not applicableStudy completedNCT01044576
What this trial is testing

Patient Research Cohort: Rapidly Evolving Multiple Sclerosis

Who this might be right for
Relapsing-remitting Multiple SclerosisSecondary Progressive Multiple Sclerosis
Imperial College London 200
Post-approval studies (Phase 4)UnknownNCT01705457
What this trial is testing

Impact of Vitamin A on RAR Gene Expression in Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Tehran University of Medical Sciences 20
Not applicableUnknownNCT02104492
What this trial is testing

Effects of a 12-week Respiratory Muscles Training Program in Persons With Relapsing- Remitting Multiple Sclerosis

Who this might be right for
Relapsing-remitting Multiple Sclerosis
University of Malaga 40
Post-approval studies (Phase 4)Study completedNCT01317004
What this trial is testing

Patients With Relapse Remitting Multiple Sclerosis (RRMS): Candidates for MS Therapy Change

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Novartis Pharmaceuticals 61
Testing effectiveness (Phase 2)Study completedNCT06812585
What this trial is testing

The Effect of Metformin As an Adjuvant Therapy on Immunological Parameters in Egyptian Patients with RRMS: a Pilot Study

Who this might be right for
Multiple Sclerosis (MS) - Relapsing-remitting
German University in Cairo 30
Not applicableStudy completedNCT06127095
What this trial is testing

Assess New Participant's Perspectives Beyond Clinical Efficacy of Monoclonal Antibody-Based Relapsing Remitting Multiple Sclerosis (RRMS) Treatments

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Biogen 474
Large-scale testing (Phase 3)Study completedNCT01874145
What this trial is testing

Safety and Tolerability of Glatiramer Acetate

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Teva Branded Pharmaceutical Products R&D, Inc. 209
Early research (Phase 1)Not Yet RecruitingNCT07562074
What this trial is testing

Transcranial Magnetic Stimulation for Depression in Multiple Sclerosis

Who this might be right for
Multiple SclerosisDepression - Major Depressive DisorderFatigue
University of Calgary 20
Not applicableStudy completedNCT06737419
What this trial is testing

Real World Effectiveness, Persistence, Tolerability, and Safety of Ofatumumab in Clinical Practice

Who this might be right for
Multiple Sclerosis
Novartis Pharmaceuticals 175
Not applicableUnknownNCT06125301
What this trial is testing

Multiple Sclerosis Self Monitoring Study

Who this might be right for
Multiple Sclerosis
Amsterdam UMC, location VUmc 225
Testing effectiveness (Phase 2)Study completedNCT01767701
What this trial is testing

Raltegravir (Isentress) Pilot Study in Relapsing Multiple Sclerosis

Who this might be right for
Relapsing Remitting Multiple Sclerosis
Queen Mary University of London 23
Not applicableUnknownNCT05752630
What this trial is testing

Physical Activity, Sedentary Behaviour and Cardiometabolic Health in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Hasselt University 50
Early research (Phase 1)Ended earlyNCT01144351
What this trial is testing

A Safety and Efficacy Study of ELND002 in Patients With Relapsing Forms of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Elan Pharmaceuticals 32
Not applicableStudy completedNCT07501520
What this trial is testing

Effect of Low Histamine-Based Modified Mediterranean Diet in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis (MS) - Relapsing-remittingMediterranean Diet
Firat University 51
Testing effectiveness (Phase 2)Study completedNCT01093326
What this trial is testing

Clinical Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Ponesimod in Patients With Relapsing-remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Actelion 353
Large-scale testing (Phase 3)Study completedNCT04788615
What this trial is testing

Open Label Randomized Multicenter to Assess Efficacy & Tolerability of Ofatumumab 20mg vs. First Line DMT in RMS

Who this might be right for
Multiple Sclerosis
Novartis Pharmaceuticals 185
Large-scale testing (Phase 3)Study completedNCT02555215
What this trial is testing

Extension Study of BG00012 in Pediatric Subjects With Relapsing Remitting Multiple Sclerosis (RRMS)

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Biogen 20
Not applicableActive Not RecruitingNCT05519553
What this trial is testing

Peer Support Impact on Therapeutic Adherence in Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-remitting
Nantes University Hospital 60
Not applicableLooking for participantsNCT05177523
What this trial is testing

Imaging the Interplay Between Axonal Damage and Repair in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis (MS)Relapsing-remitting Multiple Sclerosis (RRMS)Secondary-progressive Multiple Sclerosis (SPMS)+1 more
University Hospital, Basel, Switzerland 300
Next Page